Literature DB >> 18340247

Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.

Francesco Sardanelli1, Alfonso Fausto, Anastassia Esseridou, Giovanni Di Leo, Miles A Kirchin.   

Abstract

RATIONALE AND
OBJECTIVE: Gadobenate dimeglumine (Gd-BOPTA), a high-relaxivity contrast agent, has been recently proposed for dynamic MR imaging of the breast. The objective of this study was to optimize the diagnostic performance of Gd-BOPTA-enhanced dynamic breast MR imaging by using adjusted initial enhancement thresholds.
METHODS: Thirty-four patients with 36 breast lesions (malignant/benign = 28/8) underwent dynamic breast MRI with 0.1 mmol/kg Gd-BOPTA and 120-second time resolution. A score system based on shape (round/oval/lobular = 0; linear/dendritic/stellate = 1), margins (defined = 0; undefined = 1), pattern (homogeneous = 0; inhomogeneous = 1; rim = 2), kinetics (continuous = 0; plateau = 1; washout = 2), and initial enhancement was used. Initial enhancement was determined with standard (<50% = 0; 50%-100% = 1; >100% = 2) and adjusted (<100% = 0; 100%-240% = 1; >240% = 2) thresholds. Scores of 0 to 3 indicated benign lesions and scores of 4 to 8 malignant lesions. Diagnostic performance was assessed in terms of sensitivity, specificity, positive and negative predictive values, and overall accuracy.
RESULTS: The initial enhancement was >100% for 26 malignant and 7 benign lesions and >240% for 16 and 1 lesions, respectively. The overall score was 5.89 +/- 1.34 with standard thresholds and 5.50 +/- 1.53 with adjusted thresholds (P = 0.003) for cancers, 4.00 +/- 1.93 and 3.25 +/- 1.75 (P = 0.028) for benign lesions, respectively. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy was 96%, 13%, 79%, 50%, and 78%, respectively, with standard thresholds and 96%, 75%, 93%, 86%, and 92%, respectively, with adjusted thresholds. A ductal carcinoma in situ was false negative whereas a fat necrosis and a papilloma were false positive with both thresholds. Three fibroadenomas, 1 adenosis, and 1 fibrosis were false positive with standard thresholds but true negatives with adjusted thresholds.
CONCLUSIONS: Lesion characterization with Gd-BOPTA requires higher thresholds for initial enhancement than those used with conventional Gd-chelates, leading to improved specificity, predictive values, and accuracy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340247     DOI: 10.1097/RLI.0b013e318160678d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

1.  Computer-Aided Diagnosis Scheme for Distinguishing Between Benign and Malignant Masses in Breast DCE-MRI.

Authors:  Emi Honda; Ryohei Nakayama; Hitoshi Koyama; Akiyoshi Yamashita
Journal:  J Digit Imaging       Date:  2016-06       Impact factor: 4.056

2.  Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound.

Authors:  M L Luciani; F Pediconi; M Telesca; F Vasselli; V Casali; E Miglio; R Passariello; C Catalano
Journal:  Radiol Med       Date:  2011-02-01       Impact factor: 3.469

3.  The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases.

Authors:  Matthias Dietzel; Pascal A T Baltzer; Tibor Vag; Aimee Herzog; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

4.  A computerized global MR image feature analysis scheme to assist diagnosis of breast cancer: a preliminary assessment.

Authors:  Qian Yang; Lihua Li; Juan Zhang; Guoliang Shao; Bin Zheng
Journal:  Eur J Radiol       Date:  2014-03-22       Impact factor: 3.528

5.  Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.

Authors:  Eva M Fallenberg; Diane M Renz; Bettina Karle; Carsten Schwenke; Barbara Ingod-Heppner; Angela Reles; Florian J Engelken; Alexander Huppertz; Bernd Hamm; Matthias Taupitz
Journal:  Eur Radiol       Date:  2014-09-25       Impact factor: 5.315

6.  Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.

Authors:  M Calabrese; D Brizzi; L Carbonaro; M Chiaramondia; M A Kirchin; F Sardanelli
Journal:  Radiol Med       Date:  2009-02-04       Impact factor: 3.469

7.  Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis.

Authors:  Antonio Esposito; Marco Francone; Riccardo Faletti; Maurizio Centonze; Filippo Cademartiri; Iacopo Carbone; Roberto De Rosa; Ernesto Di Cesare; Ludovico La Grutta; Guido Ligabue; Luigi Lovato; Erica Maffei; Riccardo Marano; Massimo Midiri; Gianluca Pontone; Luigi Natale; Francesco De Cobelli
Journal:  Insights Imaging       Date:  2015-11-10

Review 8.  Use of contrast agents in oncological imaging: magnetic resonance imaging.

Authors:  Giovanni Morana; Christian Cugini; Giuliano Scatto; Riccardo Zanato; Michele Fusaro; Alberto Dorigo
Journal:  Cancer Imaging       Date:  2013-09-23       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.